OA17767A - Production of plants using somatic embryogenesis - Google Patents
Production of plants using somatic embryogenesis Download PDFInfo
- Publication number
- OA17767A OA17767A OA1201600180 OA17767A OA 17767 A OA17767 A OA 17767A OA 1201600180 OA1201600180 OA 1201600180 OA 17767 A OA17767 A OA 17767A
- Authority
- OA
- OAPI
- Prior art keywords
- embryos
- medium
- light
- primary
- somatic embryogenesis
- Prior art date
Links
- 230000030118 somatic embryogenesis Effects 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 210000002257 embryonic structures Anatomy 0.000 claims abstract description 221
- 241000196324 Embryophyta Species 0.000 claims abstract description 74
- 240000000280 Theobroma cacao Species 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 65
- 235000009470 Theobroma cacao Nutrition 0.000 claims abstract description 54
- 239000000463 material Substances 0.000 claims abstract description 48
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 230000001902 propagating Effects 0.000 claims abstract description 13
- 239000002609 media Substances 0.000 claims description 186
- 230000000392 somatic Effects 0.000 claims description 54
- 230000018109 developmental process Effects 0.000 claims description 44
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 43
- 230000001939 inductive effect Effects 0.000 claims description 41
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 38
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 38
- 239000005720 sucrose Substances 0.000 claims description 38
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 34
- 210000001519 tissues Anatomy 0.000 claims description 32
- 230000035800 maturation Effects 0.000 claims description 25
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 claims description 23
- 239000001963 growth media Substances 0.000 claims description 23
- 239000005980 Gibberellic acid Substances 0.000 claims description 22
- 230000015572 biosynthetic process Effects 0.000 claims description 21
- 238000005755 formation reaction Methods 0.000 claims description 21
- 230000013020 embryo development Effects 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 16
- 230000000243 photosynthetic Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 229940110456 cocoa butter Drugs 0.000 claims description 6
- 235000019868 cocoa butter Nutrition 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000001965 increased Effects 0.000 claims description 3
- 230000000977 initiatory Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 45
- 239000007788 liquid Substances 0.000 description 26
- 239000007787 solid Substances 0.000 description 22
- 230000035784 germination Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 210000001161 Embryo, Mammalian Anatomy 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- 210000004027 cells Anatomy 0.000 description 16
- 235000005764 cacao Nutrition 0.000 description 15
- 235000005767 cacao Nutrition 0.000 description 15
- 235000001046 cacaotero Nutrition 0.000 description 15
- 229920002148 Gellan gum Polymers 0.000 description 14
- 230000013080 embryo development ending in birth or egg hatching Effects 0.000 description 14
- 230000013144 embryo development ending in seed dormancy Effects 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- QANMHLXAZMSUEX-UHFFFAOYSA-N Kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 12
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 229930003231 vitamins Natural products 0.000 description 12
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 11
- 239000004062 cytokinin Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 7
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 7
- 229940088594 Vitamin Drugs 0.000 description 7
- 239000002363 auxin Substances 0.000 description 7
- 230000003050 macronutrient Effects 0.000 description 7
- 235000021073 macronutrients Nutrition 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000006011 modification reaction Methods 0.000 description 7
- 229960003512 nicotinic acid Drugs 0.000 description 7
- 235000001968 nicotinic acid Nutrition 0.000 description 7
- 239000011664 nicotinic acid Substances 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- LMSDCGXQALIMLM-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;iron Chemical compound [Fe].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O LMSDCGXQALIMLM-UHFFFAOYSA-N 0.000 description 6
- 229960001669 Kinetin Drugs 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- FGIUAXJPYTZDNR-UHFFFAOYSA-N Potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000011785 micronutrient Substances 0.000 description 6
- 235000013369 micronutrients Nutrition 0.000 description 6
- 229960002862 pyridoxine Drugs 0.000 description 6
- 235000008160 pyridoxine Nutrition 0.000 description 6
- 239000011677 pyridoxine Substances 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 235000019157 thiamine Nutrition 0.000 description 6
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 6
- 229960003495 thiamine Drugs 0.000 description 6
- 239000011721 thiamine Substances 0.000 description 6
- 235000013619 trace mineral Nutrition 0.000 description 6
- 229940029983 VITAMINS Drugs 0.000 description 5
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 239000005648 plant growth regulator Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000005631 2,4-D Substances 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 229940088597 Hormone Drugs 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 229960004799 Tryptophan Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000002068 genetic Effects 0.000 description 4
- 239000003630 growth substance Substances 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 239000003375 plant hormone Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- 235000019454 L-leucine Nutrition 0.000 description 3
- 239000004395 L-leucine Substances 0.000 description 3
- HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
- 229960002079 calcium pantothenate Drugs 0.000 description 3
- 239000000122 growth hormone Substances 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N Calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 241001233914 Chelidonium majus Species 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N Indole-3-butyric acid Natural products C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 229960000367 Inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N Inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 210000004080 Milk Anatomy 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N Putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N Spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 229930000028 abscisic acids Natural products 0.000 description 2
- JLIDBLDQVAYHNE-OAHLLOKOSA-N abscisin II Chemical compound OC(=O)C=C(C)C=C[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-OAHLLOKOSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 230000000442 meristematic Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 230000000921 morphogenic Effects 0.000 description 2
- 230000000877 morphologic Effects 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- GEDVVYWLPUPJJZ-UHFFFAOYSA-N (7-amino-8-methylphenothiazin-3-ylidene)-dimethylazanium;chloride Chemical compound [Cl-].N1=C2C=CC(=[N+](C)C)C=C2SC2=C1C=C(C)C(N)=C2 GEDVVYWLPUPJJZ-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-Dichlorophenoxyacetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- DVARTQFDIMZBAA-UHFFFAOYSA-O Ammonium nitrate Chemical compound [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000007170 Cocos nucifera Species 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 210000002615 Epidermis Anatomy 0.000 description 1
- UDPGUMQDCGORJQ-UHFFFAOYSA-N Ethephon Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 1
- 239000005976 Ethephon Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L Iron(II) sulfate Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 229910017234 MnSO4 H2O Inorganic materials 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 240000005158 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L Potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 241000219161 Theobroma Species 0.000 description 1
- 235000002423 Theobroma angustifolium Nutrition 0.000 description 1
- 235000002425 Theobroma bicolor Nutrition 0.000 description 1
- 235000002424 Theobroma grandiflorum Nutrition 0.000 description 1
- 235000002323 Theobroma simiarum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UHFFFAOYSA-L calcium;3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid;3-[(2,4-dihydroxy-3,3-dimethyl-1-oxidobutylidene)amino]propanoate Chemical compound [Ca+2].OCC(C)(C)C(O)C(=O)NCCC([O-])=O.OCC(C)(C)C(O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UHFFFAOYSA-L 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000020415 coconut juice Nutrition 0.000 description 1
- 238000003053 completely randomized design Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000408 embryogenic Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- -1 for example Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101710034870 ligM Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002906 microbiologic Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000021625 positive regulation of cell division Effects 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 230000000644 propagated Effects 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001172 regenerating Effects 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- FDEIWTXVNPKYDL-UHFFFAOYSA-N sodium molybdate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][Mo]([O-])(=O)=O FDEIWTXVNPKYDL-UHFFFAOYSA-N 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Inorganic materials [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
Abstract
A process for propagating Theobroma cacao L. is described. The process uses direct or indirect somatic embryogenesis to produce primary embryos from explant material, and then applies direct somatic embryogenesis to the resulting primary embryos to produce secondary embryos. These may be matured, pre-germinated, and germinated to form plantlets. Plants, plants bearing fruit, and plant materials are also provided, as well as methods for processing the fruit of the plants to generate cocoa products.
Description
This application claims the benefit of priority from British Patent Application No. 1320387.2, filed on November 19, 2013. The entiretyofthe priorityapplication is incorporated herein by reference.
FIELD OF THE INVENTION
The présent invention relates generaliy to methods of propagating Theobroma cacao plants in vitro. The methods include in vitro multiplication of direct somatic embryos (DSE) or indirect somatic embryos (ISE) using direct somatic embryogenesis, and plant régénération, as well as plants, plants bearing fruit, and plant materials obtained thereby. Methods for processing the fruit of the plants to generate cocoa products, particularly edible cocoa products are also provided.
BACKGROUND OF THE INVENTION
Theobroma cacao L. is a tropical tree originating in the Amazon, where it occurred naturally in the shade of the tropical rainforests. Cacao sub-products like butter and powder are produced as principal components of chocolaté, and contain with important compounds for nutrition as polyphenols and flavonoids, among others. However, bean production is decreasing due to the fact that many plantations are old and unproductive. Propagation of cacao has been traditionally carried out through classical propagation methods, such as grafting or rooted-cuttings, but those are not sufficient for obtaining large amounts of planting material with the desired genetic quality and plant health.
In the search for solutions to this problem, somatic embryogenesis is one of the végétative methods for propagation of cacao that shows potential for providing large quantifies of highquality planting material. Somatic embryos are formed from plant cells that are not normally involved in the development of embryos, i.e., ordinary plant tissue. Applications of the somatic embryogenesis process include: clonal propagation of genetically uniform plant
-117767 material; élimination of viruses; provision of source tissue for genetic transformation; génération of whole plants from single cells; and development of synthetic seed technology. Somatic embryogenesis is a type of clonal propagation where competent cells in the somatic tissue can develop into embryos and subsequently convert into plants. In indirect somatic embryogenesis, cells derived from competent source tissue can be cultured to form an undifferentiated mass of cells called a callus. Plant growth regulators in the tissue culture medium can be manipulated to induce callus formation and subsequently changed to induce embryos to form from the callus. The ratio of different plant growth regulators required to induce callus or embryo formation varies with the type of plant.
This method offers significant technological advantages, because it is possible to obtain a large amount of disease-free planting material with good agronomie characteristics and genetic stability. However, tissue culture techniques can be cumbersome and there is significant variation between the protocols and conditions that are required to produce different plant types or species.
The majority of the work to date in micropropagation of cacao through somatic embryogenesis uses the technique of indirect embryogenesis (Maximova et al., 2002 In Vitro Cell Dev. Biol Plant 38:252-259 and WO 2009/071254) in which undifferentiated calluses are obtained as a source of primary embryos.
WO 2009/071254 describes Theobroma cacao L. propagation by indirect somatic embryogenesis in solid or liquid media cocoa flower buds and leaves which are subjected to:
primary embryogenesis in the dark in a solid culture medium for 5 to 15 weeks for causing induction and expression to produce primary embryos, secondary embryogenesis in which the primary embryos are treated in the dark in solid or liquid media culture medium for 10 to 25 weeks to produce and multiply embryogenesis callus followed by treatment of the embryogenesis callus in the dark in a suitable liquid culture medium for 1 to 6 weeks for causing expression
-217767 of the embryogenesis callus to produce further new secondary embryos, pre-germination of the secondary embryos in a Pétri dish on a solid medium, or in a bioreactor in a liquid medium for 3 to 12 weeks, into pregerminated secondary embryos at the cotyledonary stage, ex vitro germination of the pre-germinated secondary embryos at the cotyledonary stage by sowing directly on a culture substrate in the greenhouse to produce the plantlets, and development of the plantlets.
However, such Systems require a long period to obtain somatic embryos and regenerated plants, and can resuit in a high amount of abnormal embryos. Furthermore, because of the reliance on formation of callus tissue, there is a higher probability of somaclonal variation among the regenerated plants.
In the approach of direct embryogenesis, somatic embryos may be derived from plant tissues comprising differentiated cells. The differentiated cells may include specialized cells such as the differentiated cells of cicatricial callus that forms on the epidermis of a plant, for example, in response to a wound. The differentiated cells of the expiant material used in direct somatic embryogenesis is therefore different from the undifferentiated callus used in indirect somatic embryogenesis. The method comprises the cultivation of expiants in culture media supplemented only with cytokinin, or the combination of auxin and cytokinin (Dublin, Café Cacao Thé, Paris, 25(4), 237-241, 1981; Pierson et al., Protoplasma 115, 208-216, 1983). Some authors, such as Dublin (1981), suggest that propagation by direct somatic embryogenesis is suitable for keeping the stability of the donator génotype in some species, such as coffee.
Typically processes based upon direct somatic embryogenesis involve the following sequence of steps:
Induction of direct somatic embryogenesis
Development of somatic embryos
Multiplication of direct somatic embryos
-317767
Germination of somatic embryos
Conversion in plants of somatic embryos.
However, previous attempts to apply this technique to the propagation of cacao hâve not been satisfactory. For example, it was reported by Litz, R. E. (“Tissue Culture Studies with
T. cacao,” Cacao Biotechnology Symposium, Pennsylvania State University, U.S.A. 1986) that a low frequency of somatic embryogenesis from young leaves was obtained using a semi-solid MS medium (Murashige and Skoog, 1962), supplemented with sucrose, and high levels of the synthetic auxin 2,4-dichlorophenoxyacetic acid (2,4-D) and the synthetic cytokinin 6-benzylaminopurine (BAP). The somatic embryos developed only to the heart stage. Some direct embryogenesis was observed at the base of young petal expiants from immature flowers of cacao after three weeks of culture (Sondahl, M. R. et al. “Somatic Embryogenesis and Plan Régénération of cacao.” Acta Hort. Republic of South Africa. 1993), when grown in liquid medium with different combinations of BAP, indole-3-acetic acid (IAA), gibberellic acid (GA3), abscisic acid (ABA), and 2,4-D, supplemented with coconut water and kept in the dark. The response was dépendent on génotype.
U. S. Patent No. 6,197,587 relates to methods of (i) inducing indirect somatic embryogenesis from cacao tissue expiants, and (ii) regenerating cacao plants from somatic embryos. Tissue culture media adapted for use in the methods are provided, including primary callus growth medium, secondary callus growth medium, embryo development medium, primary embryo conversion medium, secondary embryo conversion medium, and plant régénération medium. Although the process of inducing somatic embryos in cacao expiants may be carried out in the dark or under light, darkness is preferred.
U.S. Patent No. 5,312,801 relates to a method for régénération of somatic embryos from non-zygotic or zygotic tissue, and provides a means for régénération of cacao plantlets and plants from somatic embryos. Although it is indicated that somatic embryos may be derived from any source, the focus is on the use of nucellus and young flower bud petals. The methods are carried out in low light (300-100 lux, which is équivalent to 5.76-1.95 pmol/m2/sec) or in darkness.
DE 102010044562 A1 relates to automated techniques for in vitro propagation of plants based on somatic embryogenesis, and a process for forming homogenous plant clusters based on a régénération technique using stem cells from the apical meristem. The resulting directed prolifération under targeted expression of phytohormones leads to formation of homogenous secondary embryoids with unlimited prolifération ability. A nutrient medium having a composition that is adjusted to induce defined différentiation is provided for controllable plant régénération. The methods are carried out using small expiants taken from meristematic material.
The article by Vinterhalter relates to direct somatic embryogenesis in celandine (Chelidonium majus L.) using whole epicotyls expiants of seedlings after prolonged cultivation on MS medium, with or without plant growth regulators. Somatic embryos developed into plantlets, which entered additional cycles of somatic embryogenesis. Embryos that developed into rooted plantlets could be acclimated in a greenhouse.
The article by lantcheva relates to a procedure for direct somatic embryogenesis from wild Medicago spp. using various expiants, including meristematic zones (hypocotyls, cotylédons, and petiole bases from seeds). Solid medium supplemented with thidiazuron or 6-benzylaminopurine at different concentrations promoted the process. Secondary embryogenesis was also observed. Cuttings of clusters of primary and secondary embryos were used for cyclic production of new embryo générations. Regenerated plants with welldeveloped root Systems on medium with reduced levels of macroéléments and sucrose were adapted to a greenhouse.
The article by Guiltinan relates to a procedure for the stimulation of somatic embryogenesis and plant régénération from non-zygotic somatic tissues of cacao, involving the use of several culture steps in combination with the use of the synthetic cytokinin thidiazuron (TDZ) and a synthetic auxin (2,4D). Three steps are used, including callus induction, embryo development, and plant régénération. When used in the process, 100% of expiants taken from staminodes and 60% of expiants taken from petal bases produced somatic embryos, and up to 37% of the selected mature somatic embryos produced were capable of conversion into plantlets.
-517767
In contrast to the indirect somatic embryogenesis methods described in the prior art, the présent invention beneficially provides methods for producing embryos using techniques that include direct somatic embryogenesis. Accordingly, the methods of the invention beneficially provide a unique opportunity for tree breeders and cocoa researchers to improve genetic uniformity in plants for use in further testing, and/or improve yields and disease résistance in trees grown for use in cocoa production.
SUMMARY OF THE INVENTION
The présent invention meets the unmet needs of the art, as well as others, by providing methods for propagating Theobroma cacao in vitro. The methods are particularly useful for the in vitro multiplication of direct somatic embryos (DSEs) or indirect somatic embryos (ISEs) using direct somatic embryogenesis, and plant régénération. Plants, plants bearing fruit, and plant materials obtained using the methods are also provided. Methods for processing the fruit of the plants to generate cocoa products, particularly edible cocoa products.
According to one aspect, a process for propagating Theobroma cacao is provided, which may include the following steps:
(a-1) obtaining Theobroma cacao L. expiant material, followed by placing the expiant material in an induction medium with exposure to light for a period sufficient to obtain primary embryos; and optionally transferring the primary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce primary embryos by direct somatic embryogenesis;
(b-1) removing tissue of primary embryos, preferably epicotyls of primary embryos obtained after step (a-1), and optionally cutting them into pièces, followed by placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and
-617767 optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-1) to a medium configured to cause maturation ofthe secondaryembryos.
In an additional aspect, a process for propagating Theobroma cacao L. is provided, which may include the following steps:
(a-2) obtaining Theobroma cacao L. expiant material;
placing the expiant material into a callus formation medium in the dark for a period sufficient to obtain callus formation; and transferring the callus from 1) into an embryo development medium and culturing in the dark for a period sufficient to produce primary embryos by indirect somatic embryogenesis;
(b-2) removing tissue of primary embryos and optionally cutting it into pièces; placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-2) to a medium configured to cause maturation ofthe secondaryembryos.
In additional aspects, a process for propagating Theobroma cacao L. is provided in which embryos obtained through the propagation methods are pre-germinated, optionally germinated, and developed into plantlets.
Another aspect relates to a process for preparing direct secondary somatic embryos of
Theobroma cacao by a method including culturing expiants of primary somatic embryos in
-717767 induction media comprising BAP, followed by developing embryos in development media comprising gibberellic acid. Media for use in such a process are also provided. Preferably, the induction and development media also include sugar.
Other features and advantages of the présent invention will become apparent to those skilled in the art upon examination of the following or upon learning by practice of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a photograph of direct somatic embryos in globular stage from primary somatic embryo epicotyls, which were treated with 1.0 mg/l BAP and 40 g/l sucrose.
Figure 2 is a photograph of direct somatic embryos in early torpédo stage, which were treated with 0.6 mg/l gibberellic acid and 40 g/l sucrose.
Figure 3 is a photograph of a direct somatic embryo in the mature cotyledonary stage.
Figure 4 is a graph of the number of embryos produced in different concentrations of gibberellic acid and sucrose. Gibberellic acid influenced the expression of direct somatic embryos when used in combination with 40 g/L or 80 g/L of sucrose.
Figure 5 is a graph of the number of embryos in different stages (globular, heart, and torpédo) in different concentrations of gibberellic acid and sucrose. Histological analysis of cotylédon expiants showed that the tissue was composed primarily of parenchymatous and subepidermal cells having high levels of embryogénie activity. The embryonic régions developed large numbers of direct somatic embryos in globular and heart stage after 40 days of culture in induction medium containing 1.0 mg/L BAP with 40 g/L sucrose.
Figures 6A-6C are photographs that depict the morphological stages of direct somatic embryogenesis. Figure 6A shows direct somatic embryos after 40 days in induction medium exposed to light (in globular and heart stage). Figure 6B shows a cross section of cotylédons from a direct somatic embryo in the globular stage. Figure 6C shows a cross section of a cotylédon with a direct somatic embryo in the heart stage.
DETAILED DESCRIPTION OF THE INVENTION
-817767
The présent invention relates generally to methods for propagating Theobroma cacao in vitro, and particularly to methods for the in vitro multiplication of direct somatic embryos (DSEs) and indirect somatic embryos (ISEs) using direct somatic embryogenesis, followed by plant régénération, as well as plants, plants bearing fruit, and plant materials that may be obtained by the methods. Methods for processing the fruit of the plants to generate cocoa products, particularly edible cocoa products, are also provided.
Direct somatic embryogenesis is a morphological event in which somatic embryos originate directly from the plant’s tissue matrix, without the formation of callus as an intermediate stage. This is the key différence between direct and indirect somatic embryogenesis: indirect somatic embryogenesis requires callus formation. Another différence between these types of régénération is the response to the action of growth regulators. Whereas direct somatic embryogenesis is generally characterized by the cultivation of a single culture medium with the addition of just a cytokinin or another stressor agent, indirect somatic embryogenesis is generally characterized as requiring a high auxin concentration or spécifie ratios of auxin/cytokinin for callus formation in an initial culture medium. After callus is formed, another medium having no auxin or a lower concentration of auxin is used during subséquent transfers, as compared to the medium used for embryogénie callus induction.
The methods described herein, and the somatic embryos, plantlets, plants, and other plant materials disclosed herein are based in part on the surprising discovery that it is possible to induce direct somatic embryogenesis in liquid or solid media via methods that may include exposing the expiant material to light.
The methods of the invention improve the propagation process by permitting the production of embryos with reduced callus formation, and in some aspects without the formation of any embryogénie callus, thereby providing a way of obtaining a large number of normal embryos in a short time, as compared with indirect somatic embryogenesis procedures. In some aspects, the plant used to initiate somatic embryogenesis is Theobroma cacao (cacao), most preferably Theobroma cacao L. Development of mature Theobroma spp. using primary somatic embryogenesis starting from végétative plant expiants has not previously been achieved.
-917767
According to one aspect, a process for propagating Theobroma cacao is provided, the process comprising carrying out the following steps:
(a-1) obtaining Theobroma cacao L. expiant material, followed by placing the expiant material into an induction medium with exposure to light for a period sufficient to obtain primary embryos; and (ii) optionally transferring the primary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce primary embryos by direct somatic embryogenesis;
(b-1) removing tissue of primary embryos, preferably epicotyls of primary embryos obtained after step (a-1), and optionally cutting it into pièces, followed by placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-1) to a medium capable of causing maturation and pre-germination of direct secondary embryos into plants, culturing the secondary embryos in said medium for a period sufficient to allow maturation, pregermination and optionally also germination of said secondary embryos in said medium, and (d) developing plantlets from the pre-germinated or germinated secondary embryos obtained in step (c).
By conducting the process using direct somatic embryogenesis throughout stages (a-1) and (b-1), the problems associated with the use of undifferentiated callus material as discussed above are avoided. Although it may be possible to utilize the torpédo embryos attained in step (a-1 )(i) in order to provide source material for development of secondary embryos, in the case of Theobroma cacao L., it has been discovered that epicotyl material derived from primary embryos subjected to step (a-1 )(ii) provides a convenient source of expiant material for the development of secondary embryos. Furthermore, contrary to many of the previously
-1017767 described processes, it has been discovered that exposure to light during both stages (a-1) and (b-1) leads to an efficient in vitro propagation process.
However, the invention is not to be construed as only being directed to the use of direct primary and secondary somatic embryogenesis. To the contrary, according to another aspect, a process for propagating Theobroma cacao L. is provided, the process comprises carrying out the following steps:
(a-2) obtaining Theobroma cacao L. expiant material, followed by placing the expiant material into a callus formation medium in the dark for a period sufficient to obtain callus formation; and transferring the callus from 1) into an embryo development medium and culturing in the dark for a period sufficient to produce primary embryos by indirect somatic embryogenesis;
(b-2) removing tissue of primary embryos, preferably epicotyls of primary embryos obtained after step (a-2), and optionally cutting them into pièces, followed by placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-2) to a medium capable of causing maturation and pre-germination of direct secondary embryos into plants, culturing the secondary embryos in said medium for a period sufficient to allow maturation, pregermination and optionally also germination of said secondary embryos in said medium, and (d) developing plantlets from the pre-germinated or germinated secondary embryos obtained in step (c).
By conducting the process using indirect somatic embryogenesis during stage (a-2), preferably with reduced callus formation as compared to existing indirect somatic embryogenesis techniques, and direct somatic embryogenesis during stage (b-2), the higher multiplication of embryos afforded by the use of indirect somatic embryogenesis is
-1117767 beneficially provided, while the use of direct somatic embryogenesis for secondary embryo develop reduces the risk of somaclonal variation in the embryos produced. The epicotyl material derived from the primary indirect embryos subjected of stage (a-2) provides a convenient source of expiant material for the development of secondary embryos. Furthermore, contrary to many of the previously described processes, it has been discovered that exposure to light during stage (b-2) leads to an efficient in vitro propagation process.
Suitable expiant material for use in step (a-1) or (a-2) of the process of the invention may include, but is not limited to pétais, staminodes, and ovales.
The culture media used in step (a-1) may include induction media, and optionally development media, used in sequence. Each media includes components necessary for the induction and development of primary embryos as understood in the art. Thus, the media may comprise, without limitation, macro and micro salts solution with vitamins, growth hormones, and an energy source such as glucose or sucrose. However, since the process is one of direct somatic embryogenesis, the media does not contain hormones such as 2,4D. The phytohormone 2,4D is known to produce somaclonal variation and a large amount of embryos that cannot be converted into plants. However, one or more plant growth regulators or hormones may be provided in the media, including, for example, ethephon, kinetin, putrescine, spermidine, hydrogen peroxide, 6-(γ,γdimethylallylamino)purine (2iP), and gibberellic acid / gibberellin The plant growth regulators or hormones may be provided in amounts capable of supporting direct somatic embryogenesis, for example, 0.01 mg/L, 0.05 mg/L, 0.10 mg/L, 0.20 mg/L, 0.30 mg/L, 0.50 mg/L, 0.75 mg/L, 1.0 mg/L, 1.25 mg/L, 1.5 mg/L, 1.75 mg/L, 2.0 mg/L, 2.25 mg/L, 2.5 mg/L, 2.75 mg/L, or 3.0 mg/L. In the case of the plant growth hormone kinetin, where provided, it is provided in an amount of from 0.01 mg/ml to 10 mg/ml, preferably 0.1 mg/ml to 1 mg/ml, and more preferably 0.3 mg/ml to 0.5 mg/ml. Particular examples of media that are within the scope of the invention are ilIustrated below.
For step (a-2), callus formation media and embryo development media are provided. Thus, the media may comprise, without limitation, macro and micro salts solution with vitamins,
-1217767 growth hormones, and an energy source such as glucose or sucrose. According to certain aspects, because the step is based on indirect somatic embryogenesis, the phytohormone 2,4D may be included in the media, for example, in an amount of about 0.50 mg/L to 3.0 mg/L. Preferably, 2,4D is included in an amount of from 1.0 mg/L to 2.0 mg/L. Additional hormones associated with indirect somatic embryogenesis may also be included, such as the synthetic cytokinin thidiazuron (TDZ). TDZ may be included in the media, for example, in an amount from 0.5 pg/L to 10.0 pg/L. Preferably, TDZ is included in an amount from about 2.5 pg/L to 7.5 pg/L. More preferably, TDZ is included in an amount of about 5.0 pg/L.
The primary embryogenesis of step (a-1) or (a-2) is suitably carried out in a container depending upon the nature of the medium used. For example, where the medium is solid, step (a-1) or (a-2) may suitably be carried out in a Pétri dish, or where the medium is liquid, the container may comprise an Erlenmeyer flask or a reaction vessel. In the case of reactions carried out in a liquid medium, the container may be subject to agitation during or throughout the culture process.
Step (a-1) or (a-2) is continued for a period sufficient to provide primary embryos suitable for use in step (b-1) or (b-2). According to one aspect, during step (a-1) or (a-2), embryos with developed epicotyls are formed for use in step (b-1) or (b-2), respectively. Typically the development of primary embryos having developed epicotyls is achieved over a period of from 4-16 weeks, preferably 6-14 weeks, more preferably 8-12 weeks. According to some aspects, the primary embryos with developed epicotyls are obtained in about 10 weeks. During the development of the primary embryos, the température is maintained in the range of from 20-32°C, preferably from 24-28°C, and more preferably at about 27°C.
In a particular embodiment, step (a-1) may be carried out in two stages, the first stage being effected in a first culture medium specifically adapted to produce embryogenesis induction, and the optional second stage may be carried out in a second culture medium to produce embryogenesis expression and produce embryos.
In other embodiments, step (a-2) is carried out in two stages, the first stage being a callus development stage effected in a callus development medium adapted to cause callus
-1317767 formation, and the second stage is an embryo development stage carried out in a second embryo development medium to cause embryos to develop from the callus.
The salts and plant hormones used in the first culture medium used in step (a-1) may be varied. According to one aspect, the first culture medium may contain one or more growth regulators. In one preferred aspect, the growth regulators include the cytokinin 6Benzylaminopurine (BAP) and gibberellic acid, which may be used to induce direct somatic embryogenesis. According to a further aspect, a suitable first culture medium includes the following components:
Table 1
Component | Amount |
macro-nutrients MS (Murashige and Skoog, 1962) | 25% |
Micronutrients | 50% |
KH2PO4, | 20.5-80.5 mg/l, e.g. 42.5 mg/l |
Fe-EDTA, | 5-40.5mg/l, e.g. 21.5 mg/l |
pyridoxine, | 0.1-50mg/l, e.g. 1 mg/l |
nicotinic acid, | 0.1-50mg/l, e.g. 1 mg/l |
Thiamine | 1.0-500mg/l, e.g. 10 mg/l |
BAP | 0.1-2.0mg/l, e.g. 1 mg/l |
Gibberellic acid | 0.1-2.0 mg/l, e. g. 0.6 mg/L |
sucrose, | 20-120g/l, e.g. 30 g/l |
myo-inositol, | 10-200mg/l, e.g. 100 mg/l |
Phytagel (solid media only) | 1.5-2.5g/l, e.g., 2.0 g/l |
The first stage of step (a-1) may be carried out over a period of from 1-8 weeks, preferably about 2-6 weeks, and more preferably until torpedo-stage embryos are developed from the expiant material.
In aspects in which the optional second stage of step (a-1) is carried out, the medium used may also contain a cytokinin, such as BAP, but the concentration is reduced to facilitate embryo différentiation and development of embryos, as well as multiplying the numbers of embryos produced. For example, the medium used in the second stage of step (a-1) may be similar to the medium used in the first stage, but contain BAP at less than half, for example about a third, of that used in the medium used in the first stage of step (a-1). Thus where a typical medium used in the first stage of step (a-1) may contain BAP in an amount of about 1mg/l, the medium used in the second stage of step (a-1) may contain BAP in an amount of 0.3mg/l.
This second stage of step (a-1) can be effected for a period for example of from 2 to 12 weeks, preferably until the primary embryos develop epicotyls that may be used as source material for the formation of secondary embryos. During this time, the culture media may require the replenishment on multiple occasions, for example about three or four or more times through the treatment.
Step (a-1) or (a-2) is preferably carried out using expiants originating from flower buds. In one aspect, from 1 to 20 expiants will be placed in each container being used for the development of embryos, such as a Pétri dish or Erlenmeyer flask. For instance, from 2 to 10 flower buds may be placed in a Pétri dish of 100 x 20 mm or a 250ml Erlenmeyer flask, together with about 25 to 30 ml of media. During step (a-1), a multiplication of embryos, for example with an index of multiplication of from 3-10 embryos per expiant, may be observed. During step (a-2), a larger multiplication of embryos, for example with an index of multiplication of from 5-50 embryos per expiant may be observed.
At the end of step (a-1) or (a-2), the résultant primary embryos are recovered for use in direct somatic embryogenesis to produce secondary embryos. Preferably, epicotyls are removed from the embryos and eut into small pièces. Typically, each epicotyl is eut into between 4 and 6 pièces to ensure that these pièces are of suitable size for direct somatic embryogenesis. By using multiple pièces of each embryo produced in step (a-1) or (a-2) in step (b-1) or (b-2), the number of secondary somatic embryos obtainable is increased as compared with the number of primary somatic embryos generated.
The procedure of step (b-1 ) or (b-2) is carried out in light. The photoperiod may range, for example, from 12:12 to 24:0, preferably from 13:11 to 20:4, more preferably from 14:10 to 18:6. A particularly preferred photoperiod is about 16:8, with about 16 hours in the light followed by 8 hours in the dark. Exposure to light can be ensured by positioning the substrates in appropriately-illuminated chambers, as is understood in the art. A photosynthetic active radiation (PAR) or photosynthetic photon flux density (PPFD) of 30240 pmol/m2.sec may be used, preferably 50-190 pmol/m2.sec. In some aspects, for
-1517767 instance, a photoperiod of 16:8 hours light:dark and a photosynthetic active radiation (PAR) or photosynthetic photon flux density (PPFD) of 50-60 pmol/m2.sec may be used.
Step (b-1 ) or (b-2) may be carried out in two stages, the first stage being effected in a first culture medium specifically adapted to produce embryogenesis induction, and the optional second stage may be carried out in a second culture medium to produce embryogenesis expression and produce secondary embryos. The media may be either a solid or liquid medium, in a suitable container, which may be a Pétri dish or an Erlenmeyer flask as described above.
The culture medium used in step (b-1) or (b-2) is selected to encourage direct somatic embryogenesis. For instance, suitable culture media may comprise the following materials, where the Amino Acid Stock 1000X noted in Table 2 includes L-Lysine 45.65 mg, L-Leucine 32.80 mg, L-Tryptophan 51.05 mg, Arginine 43.55 mg, and Glycine 18.76 mg:
Table 2
Component | Amount |
macro-nutrients MS (Murashige and Skoog, 1962) | 100% |
Micron utrients | 100% |
calcium pantothenate | 2.0 mg/l, e.g. 1 mg/l |
Fe-EDTA, | 10-42.5 mg/l, e.g. 21.5 mg/l |
pyridoxine, | 0.1 - 50 mg/l, e.g. 1 mg/l |
nicotinic acid, | 0.1 - 50 mg/l, e.g. 1 mg/l |
Thiamine | 0.1 - 2.0 mg/l, e.g. 1 mg/l |
Biotin | 0.1 - 2.0 mg/l, e.g. 0.1 mg/l |
BAP | 0.1 -2.0 mg/l, e.g. 0.3 mg/l |
sucrose, | 20-120 g/l, e.g. 30 g/l |
myo-inositol, | 10 - 200 mg/l, e.g. 100 mg/l |
KNO3 | 0.1-3.0 g/l, e.g., 0.3 g/l |
Phytagel (solid media only) | 1.5 - 3.0 g/l, e.g., 2.2 g/l |
Amino Acid Stock Solution 1000X | 1 ml/L |
In aspects in which the optional second stage of step (b-1) or (b-2) is carried out, the medium used may also contain a cytokinin, such as BAP, but the concentration is reduced to facilitate embryo différentiation and development of embryos, as well as multiplying the numbers of embryos produced. BAP may be provided in an amount from 0.1 to 2.0 mg/L, preferably 0.5 to 1.5 mg/L, more preferably about 1.0 mg/L. For example, the medium used in the second stage of step (b-1) or (b-2) may be similar to the medium used in the first
-1617767 stage, but contain BAP at less than half, for example about a third, of that used in the medium used in the first stage of step (b-1) or (b-2). Thus, if a typical medium used in the first stage of step (b-1) may contain BAP in an amount of about 1 mg/l, then the medium used in the second stage of step (b-1 ) may contain BAP in an amount of 0.3mg/l.
In certain aspects in which both stages of step (b-1) or (b-2) are carried out, the spécifie balance between BAP/sucrose in induction medium and gibberellic acid/sucrose in development medium has surprisingly been found to be capable of inducing direct somatic embryogenesis, expression and development of normal embryos, thus promoting direct somatic embryogenesis of Theobroma cacao, and particularly Theobroma cacao L.
A principal advantage of direct somatic embryogenesis is to obtain normal embryos where the production media does not contain 2,4D. This phytohormone is known to produce somaclonal variation and a large amount of embryos that cannot be converted into plants.
In some aspects of the invention, it has been found that gibberellic acid acts as a stimulator agent for the development of normal embryos having a high capacity to convert into plants, particularly when used in combination with a sugar, such as sucrose, glucose, fructose, mannose, lactose, galactose, etc., and preferably sucrose. The secondary embryo development and maturation process in Theobroma cacao, particularly in direct somatic embryogenesis, is affected by concentration of gibberellic acid, and concentration of sucrose. The concentration of gibberellic acid may be from about 0.01 to about 1.0 g/L, preferably from about 0.2 to about 0.8 g/L, and most preferably about 0.6 g/L. The concentration of sucrose may be from about 10 g/L to about 100 g/L, preferably from about 20 g/L to about 80 g/L, and most preferably about 40 g/L. The effect of sucrose in development medium may be due to its action as an osmotic agent that induces maturation in somatic embryos.
According to a presently-preferred aspect, the induction media used in the first stage of step (b-1) or (b-2) that contains 1.0 mg/L BAP as a stressor agent for stimulating the secondary embryogénie response by direct somatic embryogenesis is associated with 40 g/L sucrose.
The development media used in the second stage of step (b-1) or (b-2) that contains 0.6 mg/l gibberellic acid is associated with 40 g/L sucrose. The use of this combination of
-1717767 induction and development media surprisingly and beneficially resulted in 83.3% of embryos produced being normal.
Without wishing to be bound by theory, it is believed that the concentration of sugar in an induction medium can be a key factor in switching on/off the spécifie type of in vitro morphogenic pathway. It is further believed that different stressor agents might induce different morphogenic responses in plant cells, such as inhibition of cell élongation, localized stimulation of cell division, and alteration ofthe cell différentiation status.
Step (b-1) or (b-2), whether carried out in one or two stages, is carried out for a period sufficient to produce secondary embryos by direct somatic embryogenesis, where the secondary embryos are suitable for use in the development of plants.
The first stage of step (b-1) or (b-2) may be carried out over a period of from 1-4 weeks, for example for about 2 weeks, preferably until torpedo-stage embryos are developed from the expiant material, which are then used in the second stage of step (b-1) or (b-2).
When only a single stage is used for step (b-1) or (b-2), the procedure of the first stage of step (b-1) or (b-2) is carried out for a period of from 2-16 weeks, preferably 2-12 weeks, more preferably 4-10 weeks, and most preferably 6-8 weeks, until the secondary embryos develop to a stage sufficient to permit them to be used in further steps toward the development of plants, for example, maturation.
When step (b-1) or (b-2) is carried out in two stages, the second stage can be effected for a period for example of from 2 to 12 weeks, preferably until the secondary embryos develop to a stage sufficient to permit them to be used in further steps toward the development of plants, for example, maturation. During this time, the culture media may require the replenishment on multiple occasions, for example about three or four or more times through the treatment. A suitable time period for step (b-1) or (b-2) may be from 2 to 12 weeks, preferably 4 to 8 weeks, and more preferably from 2 to 6 weeks.
During this time, the température is generally maintained within the range of from 23-29°C, preferably from 25-28°C. In some aspects, a température of 27°C is preferred.
The media used in the practice of the invention may be either in liquid or solid form. Solid media typically contains a gelling agent such as phytagel, although any suitable gelling
-1817767 agent may be used in order to provide solid media. According to some aspects, the use of liquid media is preferred because it can resuit in a shorter overall process for obtaining plantlets. For example, the production of embryos using solid media may take from 12-15 months from the initial production stage (7-8 months), to the maturation stage (1.5-2 months), to the germination stage (1-2 months), to the conversion stage (2-3 months). The production of embryos using primarily liquid media may take only from 8 to 11 months, from the initial production stage (6-7 months), to the maturation stage (1-1.5 months), to the germination stage (1-1.5 months), to the conversion stage (1-2 months).
The expression ‘with exposure to light’ as used herein refers to protocols and methods wherein the substrates are exposed to light for at least part of each 24 hour period. In particular the substrates are exposed to light for at least 50% of each 24 hour period, day and preferably more than this. The photoperiod may range, for example, from 12:12 to 24:0, preferably from 13:11 to 20:4, more preferably from 14:10 to 18:6. A particularly preferred photoperiod is about 16:8, with about 16 hours in the light followed by 8 hours in the dark. Exposure to light can be ensured by positioning the substrates in appropriately-illuminated chambers, as is understood in the art. In a particular embodiment, a photosynthetic active radiation (PAR) or photosynthetic photon flux density (PPFD) of 30-80 pmol/m2.sec, preferably 40-70 pmol/m2.sec, and more preferably 50-60 pmol/m2.sec is used.
In a particularly preferred embodiment, a further step may be carried out after step (b-1) or (b-2) above, but before step (c). This optional additional step, referred to herein as step (b3), is one in which the number of secondary embryos produced is multiplied further. This is effected by initiating the expression and production of new direct secondary somatic embryos from expiant material taken from the secondary embryos produced in step (b-1 )(i) or (b-2)(i) and optionally (b-1)(ii) or (b-2)(ii). The products of step (b-1) or (b-2) are transferred to a suitable liquid or solid culture medium, which may be similar to that used in the step (a-1 )(ii) or (a-2)(ii), in a suitable container as described above. The embryos are then cultured at a température of from 23-29°C, for instance from 25-28°C with exposure to light as described above. Once again, a photoperiod of 16:8 hours with 50-60 pmol/m2.seg is preferred. This step (b-3) may optionally be continued until a suitable multiplication of
-1917767 embryos has been achieved. A suitable index of multiplication of embryos at this stage may be in the range of 5-19 embryos per epicotyl expiant. This may generally be achieved in a period of from 5-10 weeks, for example, from 6-10 or 8-10 weeks. During step (b-3), the medium is changed at least once, and may be changed 3, 4, or more times during this step.
In some aspects, when step (b-3) is carried out in liquid medium in an Erlenmeyer flask, this will hâve a capacity of 250 ml and is suitably agitated throughout the procedure, for example, on a shaker at 100 révolutions per minute (rpm).
Thus the process of the présent invention, by utilizing direct somatic embryogenesis in steps (b-1), (b-2), and (b-3) (where used), provides the production of a large number of normal embryos and plantlets in a relatively short time.
The treatment of the direct secondary embryos in step (c) to produce maturation and pregermination, and optionally also germination and conversion of embryos into plants, is suitably carried out in a liquid medium. The medium may be held in any suitable container, although a temporary immersion system (TIS) reactor or in Pétri dish in solid medium are preferred aspects. Incubation is suitably effected at a température of from 23-29°C, for example from 25-28°C. While maturation is suitably effected in the dark, pre-germination and germination steps are carried out with exposure to light as described above. Again a photoperiod of 16:8 hours with 50-60 pmol/m2.sec may be suitable.
Incubation is continued for a period sufficient to allow maturation, pre-germination and optionally also germination of said secondary embryos in said medium. The medium in this case will be designed to allow these processes to proceed. A typical medium may comprise the following components, where the Amino Acid Stock 1000X noted in Table 2 includes LLysine 45.65 mg, L-Leucine 32.80 mg, L-Tryptophan 51.05 mg, Arginine 43.55 mg, and Glycine 18.76 mg:
-2017767
Table 3
Component | Amount |
macro-nutrients MS (Murashige and Skoog, 1962) | 50%-100% |
Micronutrients | 50%-100% |
calcium pantothenate | 0.1-2.0 mg/l, e.g. 1 mg/l |
Fe-EDTA, | 10-100 mg/l, e.g. 43 mg/l |
pyridoxine, | 0.1-50 mg/l, e.g. 1 mg/l |
nicotinic acid, | 0.1-50 mg/l, e.g. 1 mg/l |
Thiamine | 0.1-500 mg/l, e.g. 1 mg/l |
Biotin | 0.1-2.0 mg/l, e.g. 0.1 mg/l |
sucrose, | 20-120 g/l, e.g. 40 g/l |
myo-inositol, | 10-200 mg/l, e.g. 100 mg/l |
kno3 | 0.1-3.0 g/l, e.g., 0.3 g/l |
Amino Acid Stock 1000X | 1 ml/l |
In general, this will be complété within a period of from 6-10 weeks, for example from 8-10 weeks. Suitably, the medium will be changed on a number of occasions during this treatment, for example from 3-8 times during step (c).
The pre-germinated or germinated secondary embryos obtained in step (c) can then be developed into plantlets using conventional methods. For example, the in vitro generated materials are transplanted in the nursery for acclimatization in a culture substrate which has a mixture of components as perlite, coconut peat, soil, etc. for example. Subsequently, the plants may be transplanted in the field and grown into cocoa trees, and in preferred aspects, the plants bear fruit that may be further processed to provide cocoa products.
Ail in ail, the process of the invention may be carried out over a period of from 22 weeks to one year, preferably from 22-36 weeks, from in vitro induction to greenhouse.
Additional advantages may be achieved using the process of the invention. The organization of the steps allows for improvement in the synchronization of the occurrence and development of the embryos. Furthermore, maturation, pre-germination, germination and conversion of embryos into plants can, if required, be effected in a TIS bioreactor, thus allowing the plant propagation process to be carried out simply and with greater efficiency. The use of such bioreactors makes the process amenable to automation and provides for cost and labor savings due to factors such as the reduced need for manual steps and the use of gelling agents.
-2117767
According to one aspect in which a bioreactor is used to carry out maturation, pregermination, germination, and conversion of embryos into plants, the direct secondary somatic embryos obtained by the methods described herein may be transferred into TIS bioreactor containing liquid medium. The medium may include, for example, macronutrients MS (Murashige and Skoog, 1962) 50%, micro-nutrients MS 50%, supplemented with 43 mg/l Fe-EDTA, 1 mg/l pyridoxine, 1 mg/l nicotinic acid, 1 mg/l thiamine, 1 mg/l calcium pantothenate, 0.01 mg/l biotin, 100mg/l myo-inositol, 40 g/l sucrose and was of pH 5.8. However, other suitable media may be substituted for use in the bioreactor. After a period in the bioreactor of from 2-10 weeks, preferably 4-8 weeks, in the dark at a température of from 25-30°C, preferably 27°C, to allow for maturation, the contents are cultured in the bioreactor in the light. The culturing in light preferably uses a photoperiod of 16:8 hours at 50-60 pmol/m2.sec, although other photoperiods may be used as described above. The culturing in light is carried out at a température of from 25-30°C, preferably 27°C, for a period of from 6 to 14 weeks, preferably 8-12 weeks, and more preferably about 10 weeks. Medium should be changed at regular intervals during the treatment, such as 2, 3, 4, or more changes. During this time, the embryos undergo pre-germination, and germination. Preferably, the germinated secondary embryos obtained at the end of this process are suitable for transplantation into the greenhouse.
In addition to the methods for propagating Theobroma cacao described herein, methods for removing the fruit is removed from the plant and processing it into a cocoa product are also provided. The processing techniques used to préparé cocoa products include partially or fully depulping the fruit, fermenting the partially or fully depulped fruit using microbiological processes or chemical processes, drying the fruit by exposing it the sun or an artificial dryer, including, but not limited to, a Samoan dryer, Buttner dryer, and a platform dryer.
According to some aspects the fruit may be further roasted and winnowed to generate a nib that is converted to cocoa liquor or cocoa butter. The nib or cocoa liquor may be converted to cocoa powder. The liquor, cocoa butter, and nib may be mixed with sugar or other natural or synthetic sweetening substances. In some aspects, the resulting mixture may be in the form of a paste.
-2217767
The paste may be refined, optionally by means of a roller system, in order to generate smaller particle sizes within the paste. According to further aspects, milk solids may be added, and the mixture then further processed to a milk crumb. This mixture may be mixed in a conche, optionally with cocoa butter and emulsifier. The paste and crumb may also be mixed with cocoa butter and emulsifier in a conche. The conche used for the mixing includes, but is not limited to, a Frissee conch, a Tourell conche, Macintyre refiner/conche, and a wiener process.
The end product of this process of preparing, and optionally refining and further processing the paste is an edible cocoa containing product, including, but not limited to, chocolaté, compound chocolaté, or a chocolate-like substance.
Presently-preferred cocoa products that may be produced using the fruit from the plants propagated include cocoa liquor, chocolaté, compound chocolaté, chocolate-like substance, cocoa powder, and cocoa butter. Cocoa-containing products obtained by the processes described above are also provided.
EXAMPLES
The invention will now be particularly described by way of example. However, it will be apparent to one skilled in the art that the spécifie details are not required in order to practice the invention. The following descriptions of spécifie embodiments of the présent invention are presented for purposes of illustration and description. They are not intended to be exhaustive of or to limit the invention to the précisé forms disclosed. Many modifications and variations are possible in view of the above teachings. The embodiments are shown and described in order to best explain the principles of the invention and its practical applications, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated.
Example 1 - Primary Somatic Embryogenesis (modified from the protocol of Guiltinan et al., 1997)
-2317767
Materials
Chemicals from Sigma Chemical Co., St. Louis, MO were used for ail media préparation. Medium pH was adjusted using 1N KOH, prior to autoclaving. Ail media were autoclaved for 20 min at 121°C. A powdered form of the DKW medium developed by Driver and Kuniyuki (1984) and Tulecke and McGranahan (1985) can be obtained from Sigma Chemical Co. (D6162). However, due to the hygroscopic nature of the powdered préparation, the use of stock solutions containing the chemical components of the DKW medium is recommended for medium préparation. A hydrated powdered mixture often becomes difficult to dissolve in water, and thus may reduce the effectiveness of the medium. Macronutrients in the DKW medium were separated into A and B stock solutions in order to avoid chemical interactions between inorganic salts at high concentrations, and to prevent précipitation of salts during storage. Fresh stock solutions of growth regulators including TDZ and 2,4D; were made every 3 months. Calcium hypochlorite [Ca(OCI)2] was obtained from Aldrich Chemical Company, Inc. (Milwaukee. WI)
-TDZ solution (0.5 mg/ml): dissolve 5mg thidiazuron (Sigma P-6186) in 100 pl of 1N KOH and add dH2O to a final volume of 10 ml. Store at 4°C.
-2,4D solution (10mg/ml): dissolve 100mg 2,4-dichlorophenoxyacetic (Sigma D-8407) in 8ml of 100% éthanol, and then add H2O to 10ml. Store at 4°C.
-Kinetin and BAP solution (10 mg/ml): dissolve 10 mg kinetin or BAP in 50 pl 1 N NaOH and add H2O to 1 ml. Store at -20°C.
DKW 10X macro solution A (per liter): 14.16 g NH4NO3; 19.68 g Ca(NO3)2 4H2O. Store at 4°C.
DKW 10X macro solution B (per liter): 15.59 g K2SO4; 7.40 g MgSO4 7H2O; 1.49 g CaCI2 2H2O; 2.65 g KH2 PO4. Store at 4 °C.
-DKW 100X micro solution C (per liter): 1.70 g Zn(NO3)2 6H2O; 3.34 g MnSO4 H2O; 3.38 g
FeSO4 7H2O; 4.54 g Na-EDTA; 0.48 g H3BO3; 25 mg CuSO4.5H2O; 39 mg Na2MoO4.2H2O.
Store at 4°C.
-2417767
-DKW 1000X vitamin solution (per 100 ml): 10.0 g myo-inositol; 0.2 g thiamin-HCI; 1 g nicotinic acid; 1 g glycine; 1 g tryptophan. Distribute 1 ml aliquot to Eppendorf tube. Store 20°C.
-Primary callus growth (PCG) medium (per liter): 100 ml each of DKW solutions A and B; 10.0 ml DKW micro solution; 1 ml DKW vitamin solution; 20.0 g glucose; 250 mg glutamine;
100 mg (= 200 mg/L) myo-inositol; 200.0 μΙ (= 2.0 mg/L) 2.4-D solution; 10.0 μΙ (= 5 pg/L) TDZ solution. Adjust pH to 5.8. 2.0 g phytagel (sigma P-8169).
-Secondary callus growth (SCG) medium (per liter): 2.3 g McCown's (Lloyd and McCown. 1981) woody plant sait mixture (Sigma M-6774); 1 ml Gamborg's (Gamborg's.1966) vitamin solution (Sigma G-1019); 20.0 g glucose; 200.0 μΙ ( = 2.0 mg/L) 2.4-D solution; 5.0 μΙ ( = 0.05 mg/L) BAP solution; or 30.0 μΙ (= 0.3 mg/ml) Kinetin solution. Adjust pH to 5.8. 2.2 g phytagel.
-Embryo development (ED) medium (per liter): 100.0 ml each of DKW macro solutions A and B; 10.0 ml DKW micro solution; 1 ml DKW vitamin solution; 40.0 g sucrose. Adjust pH to 5.8. 2.0 g phytagel
Embryo development (ED) medium (per liter): 100.0 ml each of DKW macro solutions A and B; 10.0 ml DKW micro solution; 1 ml DKW vitamin solution; 30.0 g sucrose; 2.0 g phytagel. Adjust pH to 5.8
Embryo development (EDL) medium (per liter): 100.0 ml each of DKW macro solutions A and B; 10.0 ml DKW micro solution; 1.0 ml DKW vitamin solution; 20.0 g glucose; 0.3 g KNO3; 1.8 g Phytagel. Adjust pH to 5.8
Amino Acid Stock Solution 1000X (1 ml/L each): L-Lysine 45.65mg/L; L-Leucine 32.80mg/L; L-Tryptophan 51.05mg/L; Arginine 43.55mg/L; Glycine 18.76mg/L;
-Plant régénération (PR) medium (per liter): 50 ml each of DKW macro solutions A and B; 5 ml DKW micro solution; 0.5 ml DKW vitamin solution; 4.5 mg/l IBA ; 10.0 g glucose; 5.0 g sucrose; 0.3 g KNO3. Adjust pH to 5.8. 1.8 g phytagel.
-Other solutions: 95% (v/V) éthanol prepared with stérile H2O.
-Equipment: Laminar flow hood, dark incubation area with a constant température at 25 ± 2°C and light incubation area with daily cycle of 16 h (light) photoperiod (50 - 190 pmol m’2 s'1)·
-Supplies: stérile 50 ml conical-bottom centrifuge tubes, stérile 100 x 15 mm Pétri dishes, G7 magenta vessels, Pyrex brand laboratory bottles (1 and 0.5 liter), No.11 scalpel blades with handle, micro forceps, low - température electric tape, stérile paper towels and Métro mix 300 soil mixture (Scotts Sierra Horticultural Product Co. Marylandsville. OH)
Plant materials: Unopened 5 to 8 mm in immature cacao flower buds (varies with génotype), collected between 8 am and 11 am in the morning.
Procedure
Staminodes and pétais base tissues were used as culture expiants. Although immature flower buds with a range of sizes can be collected, large flower buds should be chosen since such flower buds are easier to dissect and handle in the absence of a dissecting microscope. In addition, staminodes and petal base expiants should be separated from associated floral parts such as stamen filaments and petal tissue, in order to minimize possible interactions that may affect the in vitro growth of expiants.
Collection of immature flower buds in a 50 ml centrifuge tube containing cold water was carried out in the morning before 9:00 am.
Prépare 1% (w/v) calcium hypochlorite solution by dissolving 0.5 g Ca(OCL)3in 50 ml stérile water in a stérile 50 ml centrifuge tube.
Inside the transfer hood, decant the cold water from the centrifuge tube containing the immature flower buds and transfer ail the flower buds into the stérile centrifuge tube containing the calcium hypochlorite solution.
Immerse flower buds in the calcium hypochlorite solution for 20 min. Remove ali the solution and add 40 ml stérile water to rinse flower buds. Rinse at least 3 times.
Transfer flower buds to a Pétri dish, and cover the plate to prevent desiccation.
Dissection of flower bud and callus induction
Place two to three layers of stérile paper towels in the transfer hood. Blot dry 4 flower buds on the top surface of the paper towels, and then transfer then onto a Pétri dish cover.
-2617767
SJice the flower buds across at a position of about 1/3 of the flower length from the base using a stérile scalpel blade. Extract staminodes and petal base tissues together from the part of the flower bud using a pair of stérile forceps. Remove any attached petal tissue from the petal base expiants.
Transfer staminodes and petal base expiants from 4 flower buds into a Pétri dish containing 30 ml of PCG medium. Separate any fused staminodes and petal base expiants and distribute expiants evenly across the medium.
Seal the Pétri dishes with double layers of parafilm and maintain cultures in the dark at 25 ± 2 °Cfor 14 days.
Transfer the staminodes expiants to a Pétri dish containing 30 ml of SCG medium, and the petal base expiants to another identical Pétri dish. Seal the dishes and maintain culture in the dark for another 14 days.
Somatic embryo expression and maintenance
Transfer staminodes and petal base expiants to Pétri dishes containing 30 ml of ED4 medium culture expiants in the dark for 14 days.
Subculture expiants onto fresh ED3 medium 3-5 fîmes. Maintain embryo cultures in the dark with a subculture interval of 14 days until somatic embryos reach maturity.
Secondary somatic embryogenesis process
Take epicotyls of primary embryos with 10-40 mg of weigh up and eut in pièces, and place in a Pétri dish with 30ml of SCG medium (with BAP or Kinetin depending on the spécifie génotype) or in flask with 25ml of SCG liquid medium per 14 days in the light with photoperiod 16h light:8h darkness. Put the flasks in a shaker at 100rpm to incubation in température 25-30 °C
Transfer the pièces to a Pétri dish containing 30 ml of ED4 medium culture or in flask with
25ml of ED3 liquid medium per 14 days in the light with photoperiod 16h light:08h darkness.
Put the flasks in a shaker with 10Orpm for incubation in température 25-30 °C.
-2717767
Subculture expiants onto Pétri dish containing 30 ml fresh ED3 solid medium or in flask with 50 ml of ED3 liquid medium per 14 days in the light with photoperiod 16h light:08h darkness. Put the flasks in a shaker with 100rpm for incubation in température 25-30 °C.
Transfer the embryos in heart or early torpédo stage and put in bioreactor with a concentration of 10-40 mg/ml of ED3 liquid medium with temporary immersion 6 times a day with 2 minutes per immersion and change the liquid medium every 20-30 days (1 or 2 times). Incubation in 25-30°C with photoperiod 12h light:12h darkness.
Embryo conversion and plant establishment in liquid medium
In this period the embryos are maturated and it is necessary to change the medium to EDL liquid medium (concentration 100mg/ml) with temporary immersion 6 or 8 times a day, with 2 or 1 minutes per immersion, and change the liquid medium every 20-30 days (1 or 2 times) until the embryos hâve radicles and 3-5 leaves. Then transfer to a greenhouse for acclimatization. Incubate at 25-30°C with a photoperiod of 12h light: 12h darkness.
For type I embryos, select germinated embryos and transfer them onto Pétri dishes containing 30 ml PR medium.
Maintain cultures under light with a 24 - h photoperiod 14 days.
Transfer the embryos that turn green with roots and shoots to PR medium in Magenta vessel.
Maintain cultures as described in steps 15 with subculture into fresh PR medium every 14 days.
Transplant plantlets with developing green leaves and healthy taproots into 4 - inch plastic pots containing stérile Metro-Mix 300 soil mixture. Pour water into pot to saturate the soil mixture. Cover the plantlet using a Magenta vessel. Maintain plants in the greenhouse with an 80% humidity controlled by an automatic misting system. Add water regularly to maintain an adéquate moisture content for optimal plant growth.
When the plant produces new leaves, remove the cover vessel. Apply a regular amount of fertilizers to enhance plant growth.
Expiants should be subcultured to fresh medium every two weeks. Growth réduction, senescence, and tissue browning may occur with subculture intervals longer than 14 days.
-2817767
Two types of somatic embryos can be identified based on the following characteristics: Type I embryos axis. During extended culture on ED medium, mature Type I embryos tend to remain dormant. After transfer to EDL medium, these embryos show extensive cotyledonary growth, followed by the development of true leaves. Root development in germinating Type I embryos is normally slow. Type 11 somatic embryos are whitish in color and hâve a defined embryonic axis structure. These embryos undergo spontaneous germination upon reaching maturity on ED medium. After transfer to EDL medium, these embryos turn green quickly, exhibit a significant hypocotyl élongation, and produce a strong taproot, within a short period of time. Epicotyl and production of true leaves often occur 2 to 3 weeks after transfer.
Example 2 - Use of epicotyls for induction and expression of embryos by direct somatic embryogenesis, and production of embryos in mature cotylédon stage Primary somatic embryo development
Primary somatic embryos were obtained using the methodology described by Li et al. (1998). Ail ofthe reagents used in this experiment are Sigma brand.
Collect immature flower buds of Theobroma cacao L. from CCN-10 clones in a 50 - ml centrifuge tube containing cold water in the morning before 9:00 am.
Préparé 1% (w/v) calcium hypochlorite solution by dissolving 0.5 g Ca(OCL)3 in 50 ml stérile water in a stérile 50 ml centrifuge tube.
Inside the transfer hood, decant the cold water from the centrifuge tube containing the immature flower buds and transfer ail the flower buds into the stérile centrifuge tube containing the calcium hypochlorite solution.
Immerse flower buds in the calcium hypochlorite solution for 25 min. Remove ail the solution and add 40 ml stérile water to rinse flower buds. Rinse at least 3 times. Transfer flower buds to a Pétri dish, and cover the plate to prevent desiccation.
Place two to three layers of stérile paper towels in the transfer hood. Blot dry 4 flower buds on the top surface of the paper towels, and then transfer then onto a Pétri dish cover.
Slice the flower buds across at a position of about 1/3 of the flower length from the base
-2917767 using a stérile scalpel blade. Extract staminodes and petal base tissues together from the part of the flower bud using a pair of stérile forceps. Remove any attached petal tissue from the petal base expiants.
Transfer the staminodes and petal base expiants to a Pétri dish containing 30 ml of PCG medium. Seal the dishes and maintain culture in the dark for 14 days, after, follow with the transferences to SCG medium per 14 days, after this culture period, transfer the expiant in ED4 medium per 14 days and then to ED3 medium for expression of embryos for three or four times from 14 days. Seal the Pétri dishes with double layers of parafilm and maintain cultures in the dark at 25 ± 2 °C. Table 4 compares the components of different media used in the production of primary embryos.
Table 4. Composition of PCG, SCG, ED4 and ED3 medium f .........................KRrMÂRY'soÎ^TfcÏÏMB'RYHGEÏÎESÎrMÉMEMTBVÎNDlREÏP/lA' j
PCG MEDIUM | ll | SCG MEDIUM | ll | ED-4 | ll | ED-3 | ll i |
dkw Macro A (lox) | 100 mL | McCown's wpm (Macro) | 100% | DKW Macro A (10X) | 100 mL | dkw MacroA(iox) | 100 mÜ |
DKW Macro B (1ÛX) | 100 mL | McCown's WPM (Micro) | 100% | DKW MacroB(lOX) | 100 mL | DKW Macro B (10X) | 1Q0mL| |
DKW Micro (100X) | 10 mL | DKW Micro (100X) | 10mL | DKW Micro (100X) | 10 mL! | ||
DKW Vitamins (1000X) | 1 mL | Gamborg 85 Vitamins ( 1000X) | ImL | DKW Vitamins (1000X) | 1 mL | DKW Vitamms (1000X) | 1 mL! |
Glucose | 20 g | Glucose | 20 g | Sucrose | 40 g | Sucrose | 30 g! |
2/-D (img/ml) | 2000 pL | 2,4-D (lmg/ml) | 2000 pL | i 1 | |||
TDZ (lmg/ml) | 25 pL | 61) AP (lmg/ml) | 50 pL | t t | |||
i t | or | or | t t | ||||
t t | Kinetin (img/mL) | 300 pL | ( r | ||||
Glutamine | 250 mg | t t | |||||
t'........... — 1 ................ Llyo-lnositol | 100 mg | t 1 | |||||
:pHto58wrth1UKOH | pHto 58 with 11,i ΚΟΗ | pHto58 with 11,1 KOH | pH to 5 8 with lî.l KOH | t | |||
Phytage! | Phytagel | 22g | Phytagel | 2g | Phytagel | 2 g! | |
Autoclave | 18 minutes | Autoclave | >8 minutes | Autoclave | 18 minutes | Autoclave | 18 minutes: |
For the production of secondary embryos, epicotyls are taken from primary somatic embryos with size 1 cm and 40 mg of weight and they were eut in 10-15 pièces and placed into flask with 25 ml of liquid medium for embryogénie induction (Table 5) with some modifications in the experimental design (Table 7) per 5 weeks (step c). The culture is exposed to a light:dark 16:8 photoperiod, at a température of 27 ± 2°C and photosynthetic active radiation (PAR) or photosynthetic photon flux density (PPFD) of 50-190 pmol/m2 per second.
After this period, the somatic embryos in globular stage are transferred into the Pétri dish in semi-solid developing media (Table 6) with some modifications (Table 8), with a 21-day culture period in light conditions until the embryos express and develop to the heart or early
-3017767 torpédo stage.
Afterward, the cultures were transferred into the Pétri dish in the same medium, but without gibberellic acid and with the same culture conditions but in the dark with transferences every 14 days for embryo's maturation.
Table 5. Induction media
Component | Amount |
macro-nutrients MS (Murashige and Skoog, 1962) | 25% |
Micronutrients | 50% |
KH2PO4, | 20.5-80.5 mg/l e.g. 42.5mg/l |
Fe-EDTA, | 5-40.5mg/l e.g. 21.5mg/l |
pyridoxine, | 0.1-50mg/l e.g. 1mg/l |
nicotinic acid, | 0.1-50mg/l e.g. 1mg/l |
Thiamine | 1.0-500mg/l e.g. 10 mg/l |
BAP | 0.1-2.0mg/l e.g. 1 mg/l |
sucrose, | 20-120g/l e.g. 30g/l |
myo-inositol, | 10-200mg/l e.g. 100mg/l |
Phytagel (solid media only) | 1.5-2.5g/l e.g., 2.0 g/l |
Table 6. Development medium
Component | Amount |
macro-nutrients MS (Murashige and Skoog, 1962) | 100% |
Micronutrients | 100% |
calcium pantothenate | 2.0 mg/l e.g. 1mg/l |
Fe-EDTA, | 10 - 42.5 mg/l e.g. 21,5mg/l |
pyridoxine, | 50 mg/l e.g. 1mg/l |
nicotinic acid, | 50 mg/l e.g. 1 mg/l |
Thiamine | 2.0 mg/l e.g. 1 mg/l |
Biotin | 2.0 mg/l e.g. 0.1 mg/l |
BAP | 2.0 mg/l e.g. 0.3 mg/l |
sucrose | 20- 120 g/l e.g. 30g/l |
myo-inositol | 10 - 200 mg/l e.g. 100mg/l |
Amino Acid Stock Solution 1000X | 1 ml/L |
Phytagel (solid media only) | 1.5 - 3.0g/l e.g., 2.2 g/l |
Identification of hormone balance for direct secondary somatic embryogenesis
A variety of media were tested to assess the concentrations of plant hormones and
-3117767 stressors to be used in direct secondary somatic embryogenesis, as set forth in the following tables:
Table 7. Embryogénie induction media
CLOUE CCN10 | MEDIA LIQUID CATIE | AMBIENTAL CONDITION | EXPLANT COTYLEDOS | IN0CULUM CONCENTRAT! ON | CONCENTRATION GIBER1LINE tMG/U | CONCENTRATION SUCROSE (g/IJ | REPUCATE5 NUMBER |
21 (Joys in ligM ofter 21 days in dark maturation TEMPERATURE 25^-27^ | 5 PRIMARY EMBRY0S PER 50 Ml 0Γ MEOIA | 0 | 40 80 | 5 5 | |||
0,2 | 40 80 | 5 5 | |||||
0A | 40 00 | 5 5 | |||||
0,0 | 40 80 | 5 5 | |||||
1,0 | 40 00 | 5 5 |
Table 8. Development medium (CATIE)
CLONE | MEDIA | AMBIENTAL CONDITION | EXPLANT | INOCÜLUM CONCENTRATION | CONCENTRATION BAP (Mg/1) | CONCENTRATION SUCROSE | REPLICATÉ5 | NUMBER 1 |
5 i 5 i | |||||||
PHOTDPERIDD | 1 PRIMARY EMBRYÛS PERSO ML OF MEDIA | 40 | 5 ; i 5 ; | ||||
CCN5Û | LIQUID | 16:8 | COTYLEDOS | 1.0 | 5 i | ||
YASUDA | TEMPERATURE | 5 ! | |||||
25OC-27°C | 80 | 5 ! 5 i | |||||
5 5 i |
Histological Study - Procedure
Cotylédon expiants were collected 40 days after induction and were used for study. Samples were fixed with FAA [10% formalin, 5% acetic acid, 50% éthanol (v/v)] per 8 days. The sample must be previously eut into approximately 0.5 to 1.0 mm. Do three (3) washes of 5 minutes each with distilled water or buffer to remove the fixative. Dewater the material in increasing concentrations of éthanol for at least 1h of 70%, 85% and 95% at room température (incubation time varies with the kind ofthe material).
Each sample is incubated in 1 ml of 1:1 (v / v) Basic historesin + 95% éthanol for 1 h in a desiccator négative pressure on the vacuum pump négative pressure (5-10 psi). The samples are transferred to pre-infiltration solution consisting of 1:1 (resin / activator) + 95% éthanol. And incubated in a glass dessicator environmental température ovemight. The material is transferred to 500 μΙ solution of basic historesin and must remain for at least 24 hours in refrigerator.
The material is transferred to the inclusion solution. Historesin should be removed from the refrigerator with hardener with an hour of antecedence and placed at environmental température. For each form requires nine (9) blocks Historesin, 3.5 ml of basic solution and 0.25 ml activator solution. Distribute in the form until filling it up and leave it in the lab table in environmental température for 1h until the solution is slightly firm to include the material. Then include the végétal material and leave it in incubator 45°C per 24h, after, the material in block is left in environmental température per 3h. The resin blocks are removed from the form and they are pasted in a woody table with 2.5mm/2.0mm of area. The samples are cutting in microtome LAICA model MR 1345 with glass knife of 8,0pm density and stained with 0.5% toluidine blue in 0.1 M phosphate buffer pH 6.5.
Evaluation and Statistical Analysis
Since the experiments were established, évaluations hâve been performed every 14 days, and some dépendent variables like: number of calluses formed, number of normal embryos without callus formation, number of abnormal embryos without callus formation, number of pro-embryogenic masses, number of torpédo embryos, number of heart embryos, number of globular embryos, and overall observations. The Dino-Lite digital microscope premier, AM4113/AD4113 sériés was used for the observations.
Statistical analysis was performed using the R Core Team (2014) statistical program. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. U RL http://www.R-project.org/.
Results of analysis of hormone balances and stressor agents for direct secondary somatic embryogenesis
The experiment was a sequence of médiums where the first was induction medium (Table 7) followed by combination with develop medium (Table 8). The factorial analysis was 5X2,
-3317767 in view of the testing of 2 sucrose concentrations (40 and 80 g/l) and 5 gibberellic acid concentrations (0.0, 0.2, 0.4, 0.6 and 1.0 mg/l), using a completely randomized design.
The first step for production of direct secondary somatic embryos is believed to be the induction of the compétence of cells that was stimulated by stressors in the induction medium. For that, an analysis of the corrélation between BAP and sucrose concentrations with the following sequence of médiums containing gibberellic acid for expression and develop embryos in the developing medium. The embryos were expressed and developed in the sequence of médiums. The sequence described below was deemed the best treatment for production of direct secondary embryos:
Step 1 induction: 1.0 mg/l BAP with 40 g/l sucrose in light conditions for 40 days for expression somatic embryos (see Figure 1);
Step 2 Expression: 0.6 mg/l Gibberellic acid associated with 40g/l sucrose in light 21 days for develop and maturation of embryos (see Figure 2);
Step 3 developing and maturation: The same medium as in Step 2, but without gibberellic acid for 3 transferences in darkness. 21-60 days was required for maturation (see Figure 3). The sequence of médiums mentioned above resulted in 83.3% normal embryos, as compared with the treatment with 1 mg/l of gibberellic acid and 40 g/l of sucrose, which was the treatment that produced the highest quantity of abnormal embryos (see Figure 4).
It will, of course, be appreciated that the above description has been given by way of example only and that modifications in detail may be made within the scope of the présent invention.
Throughout this application, various patents and publications hâve been cited. The disclosures of these patents and publications in their entireties are hereby incorporated by reference into this application, in order to more fully describe the state of the art to which this invention pertains.
The invention is capable of modification, alteration, and équivalents in form and function, as will occur to those ordinarily skilled in the pertinent arts having the benefit of this disclosure.
While the présent invention has been described for what are presently considered the
-3417767 preferred embodiments, the invention is not so limited. To the contrary, the invention is intended to cover various modifications and équivalent arrangements included within the spirit and scope ofthe detailed description provided above.
Claims (10)
1. A process for propagating Theobroma cacao comprising: either (a-1) obtaining Theobroma cacao L. expiant material, followed by (i) placing the expiant material into an induction medium with exposure to light for a period sufficient to obtain primary embryos; and (ii) optionally transferring the primary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce primary embryos by direct somatic embryogenesis;
(b-1 ) removing tissue of primary embryos, followed by (i) placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and (ii) optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-1) to a medium configured to cause maturation ofthe secondary embryos:
or (a-2) obtaining Theobroma cacao L. expiant material;
(i) placing the expiant material into a callus formation medium in the dark for a period sufficient to obtain callus formation; and (ii) transferring the callus from 1) into an embryo development medium and culturing in the dark for a period sufficient to produce primary embryos by indirect somatic embryogenesis;
(b-2) removing tissue of primary embryos;
(i) placing the tissue into an induction medium with exposure to light for a period sufficient to obtain secondary embryos; and
-3617767 (ii) optionally transferring the secondary embryos from (i) into a development medium and culturing them with exposure to light for a period sufficient to produce secondary embryos by direct somatic embryogenesis;
(c) transferring the secondary embryos from step (b-2) to a medium configured to cause maturation of the secondary embryos.
2. A process according to claim 1, wherein in step (a-1) the first culture medium comprises a higher concentration of 6-Benzylaminopurine (BAP) than the second culture medium.
3. A process according to claim 1 or claim 2 wherein a further step is carried out after step (b-1) or (b-2) above and before step (c), in which the products of step (b-1) or (b-2) are transferred to a medium suitable for initiation, expression and production of new direct secondary somatic embryos and incubated therein with exposure to light until the number of secondary embryos therein is increased.
4. A process according to any one of the preceding claims wherein the expiant material for use in step (a-1) or (a-2) comprises pétais, staminodes, and epicotyls of primary embryos of Theobroma cacao L.
5. A process according to any one of the preceding claims wherein the température during steps (a-1) or (a-2) and/or (b-1) or (b-2) and/or (c) is in the range of from 23-29°C and/or wherein during step (a) and step (b), cultures are in the light for at least 50% of each 24 hour period, for example wherein the photoperiod is a 16hour:8hour (light:dark) with a photosynthetic active radiation (PAR) of 50-60 pmol/m2. sec.
-3717767
6. A process for propagating Theobroma cacao L. according to any one of the preceding claims, further comprising pre-germinating, optionally germinating, and developing embryos obtained by the propagation methods into plantlets.
7. A process for preparing direct secondary Somalie embryos of Theobroma cacao L. comprising culturing primary somatic embryos in an induction media comprising BAP, followed by developing embryos in a development media comprising gibberellic acid.
8. The process of claim 7, in which the induction and development media also includes sugar, wherein the sugar is suitably sucrose, and is présent in an amount of from 20 g/L to 80 g/L.
9. The process of any one of the previous claims wherein there is a further step of propagating the embryos or plantlets into plants bearing fruit.
10. The process of claim 9 wherein the fruit is removed from the original plant and processed into a cocoa product, such as cocoa liquor, chocolaté, compound chocolaté, chocolate-like substance, cocoa powder or cocoa butter.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1320387.2 | 2013-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA17767A true OA17767A (en) | 2017-11-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rout et al. | In vitro manipulation and propagation of medicinal plants | |
Germana et al. | Organogenesis and encapsulation of in vitro-derived propagules of Carrizo citrange [Citrus sinensis (L.) Osb.× Poncirius trifoliata (L.) Raf] | |
Huy et al. | In vitro polyploid induction of Paphiopedilum villosum using colchicine | |
Chen et al. | Induction of repetitive embryogenesis from seed-derived protocorms of Phalaenopsis amabilis var. formosa Shimadzu | |
Niknejad et al. | In vitro plant regeneration from protocorms-like bodies (PLBs) and callus of Phalaenopsis gigantea (Epidendroideae: Orchidaceae) | |
Tian et al. | Plant regeneration through protocorm-like bodies induced from rhizoids using leaf explants of Rosa spp. | |
Garcia et al. | Somatic Embryogenesis in Theobroma cacao L. | |
Thiruvengadam et al. | High-frequency shoot regeneration from leaf explants through organogenesis in bitter melon (Momordica charantia L.) | |
Thiruvengadam et al. | Development of an embryogenic suspension culture of bitter melon (Momordica charantia L.) | |
US10701876B2 (en) | Production of plants using somatic embryogenesis | |
Hasbullah et al. | Establishment of somatic embryogenesis from Gerbera jamesonii Bolus EX. Hook F. through suspension culture | |
Bhargava et al. | A modified and improved protocol development for in vitro clonal propagation of Santalum album L. from internodal explants | |
HASANI et al. | Somatic embryogenesis of Ferula assa-foetida | |
Shekhawat et al. | Somatic embryogenesis and in vitro flowering in Hybanthus enneaspermus (L.) F. Muell.–A rare multipotent herb | |
Giri et al. | Plant biotechnology: practical manual | |
Azadi et al. | Somatic embryogenesis in Rosa hybrida | |
Simoes et al. | New approaches for shoot production and establishment of in vitro root cultures of Cleome rosea Vahl. | |
Islam et al. | Efficient in vitro cultural techniques for seeds germination of Vanda roxburghii | |
Ormerod et al. | Anther and microspore culture of Lupinus albus in liquid culture medium | |
OA17767A (en) | Production of plants using somatic embryogenesis | |
Assani et al. | Date palm cell and protoplast culture | |
Vooková et al. | Study of Abies somatic embryogenesis and its application | |
US7888099B2 (en) | Methods for producing a synchronized population of conifer somatic embryos | |
Gopi et al. | In vitro plant regeneration through somatic embryogenesis in medicinally important leaf explants of Coleus forskohlii Briq | |
Arli et al. | Systematic Literature Review: The Aplication Of Thin Cell Layer (TCL) Technique In Orchid Plant Propagation |